Intravesical Infusion of Resiniferatoxin by a Temporary in Situ Drug Delivery System to Treat Interstitial Cystitis: A Pilot Study

European Urology

Volumn 45, Issue 1, 2004, Pages 98-102

  Lazzeri, M ^a   Spinelli, M ^b   Beneforti, P ^a   Malaguti, S ^b   Giardiello, G ^c   Turini, D ^a  

^a UNIVERSITY OF FERRARA   (Italy)

^b Ospedale di Magenta   (Italy)

^c Medtronic Italia   (Italy)

Author keywords

Interstitial cystitis; Intravesical therapy; Resiniferatoxin; Sensory nerves

Indexed keywords

RESINIFERATOXIN;

ADULT; ARTICLE; CATHETER; CLINICAL ARTICLE; DRUG DELIVERY SYSTEM; FEMALE; HUMAN; INFUSION PUMP; INTERSTITIAL CYSTITIS; MOTOR DYSFUNCTION; NOCTURIA; PAIN ASSESSMENT; PELVIS PAIN SYNDROME; PILOT STUDY; PRIORITY JOURNAL; SENSORY DYSFUNCTION; SIDE EFFECT; URETHRA; URINARY FREQUENCY; URINARY URGENCY;

EID: 0346118847     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0302-2838(03)00418-4     Document Type: Article

References (21)

1. Guerrier HP, Roberts J, Slade N. Anti-inflammatory agents in the management of interstitial cystitis. Br J Urol 1965;37:88.
2. Messing EM, Stamey TA. Interstitial cystitis: early diagnosis, pathology and treatment. Urology 1978;12:381.
3. Baskin LS, Tanago EA. Pelvic pain without pelvic organs. J Urol 1992;147:683.
4. Maggi CA, Barbanti G, Santiccioli P, Beneforti P, Misuri D, Meli A, et al. Cystomanometric evidence that capsaicin-sensitive nerves modulate the afferent branch of micturation reflex in humans. J Urol 1989;142:150.
5. Lazzeri M, Beneforti P, Benaim G, Maggi CA, Lecci A, Turini D. Intravesical capsaicin for treatment of severe bladder pain: a randomized placebo controlled study. J Urol 1996;156:947.
6. Cruz F, Guimaraes M, Silva C, Reis M. Suppression of bladder hyperreflexia by intravesical resiniferatoxin. Lancet 1997;9078:640.
7. Lazzeri M, Beneforti P, Turini D, Barbagli G, Palminteri E. Single dose of intravesical resiniferatoxin for the treatment of interstitial cystitis: preliminary results of a randomised controlled study. J Urol 2000;163(Suppl):260A.
8. Bortolotti M, Coccia G, Grossi G. Red pepper and functional dyspepsia. N Engl J Med 2002;346(12):947.
9. Simon LJ, Landis RJ, Tomaszewski JE, Nyberg LM. The interstitial cystitis data base study. In: Sant GR, editor. Interstitial cystitis. Philadelphia: Lippincott-Raven; 1997. p. 17-24.
10. The standardisation of terminology of lower urinary tract function. http://www.icsoffice.org/.
11. Steers WD, Tuttle JB. Neurogenic inflammation and nerve growth factor: possible roles in interstitial cystitis. In: Sant GR, editor. Interstitial cystitis. Philadelphia: Lippincott-Raven; 1997. p. 67-75 [Chapter 8].
12. Maggi CA. Pharmacology of the efferent function of primary sensory neurons. In: Geppetti P, Holzer P, editors. Neurogenic Inflammation. New York: CRC Press; 1996. p. 81-90 [Chapter 7].
13. Lecci A, Giuliani S, Lazzeri M, Benaim G, Turini D, Maggi CA. The behavioral response induced by intravesical instillation of capsaicin in rats is mediated by pudendal urethral sensory fibers. Life Science 1994;55:429.
14. Green PG, Miao FJP, Jänig W, Levine JD. Negative feedback neuroendocrine control of the inflammatory response in rats. J Neurosci 1995;15:4678.
15. Strausbaugh HJ, Green PG, Lo E, Tangemann K, Reichling DB, et al. Painful stimulation suppresses joint inflammation by inducinh shedding of L-selectin from neutrophils. Nat Med 1999;5: 1057.
16. Avelino A, Cruz F, Coimbra A. Intravesical resiniferatoxin desensitizes rat bladder sensory fibres without causing intense noxious excitation. A c-fos study. Eur J Pharmacol 1999;378:17.
17. Szolcsanyi J, Szallasi A, Szallasi Z, Joò F, Blumberg PM. Resiniferatoxin: an ultrapotentn selective modulator of capsaicin-sensitive primary afferent neurons. J Pharm Exp Ther 1990;255: 923.
18. Silva C, Avelino A, Souto-Moura C, Cruz F. A light- and electron-microscopic histopathological study of human bladder mucosa after intravesical resiniferatoxin application. BJU Int 2001;88(4): 355-60.
19. Dasgupta P, Chandiramani V, Parkinson MC, Beckett A, Fowler CJ. Treating the human bladder with capsaicin: is it safe. Eur Urol 1998; 33:28-31.
20. Szallasi A, Fowler CJ. After a decade of intravesical vanilloid therapy: still more questions than answers. Lancet Neurol 2002; 1(3): 167-72.
21. Giannantoni A, Di Stasi SM, Massoud R, Stephen RL. Stability of resiniferatoxin stock solutions. Urodinamica. Neurourology, Continence and Pelvic Floor. In press.